Cover Image
市場調查報告書

全球顱內支架市場未來趨勢

Global Intracranial Stents Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 316422
出版日期 內容資訊 英文 75 Pages
訂單完成後即時交付
價格
Back to Top
全球顱內支架市場未來趨勢 Global Intracranial Stents Market 2014-2018
出版日期: 2014年10月15日 內容資訊: 英文 75 Pages
簡介

所謂顱內支架,是使用不鏽鋼製的網狀管,兼具半徑方向的強度和彈性的解剖學性特徵。用於腦動脈瘤和顱內動脈瘤、顱內動脈粥狀硬化症等疾病──約佔缺血性中風全患者中的8%──的治療。所謂動脈瘤,是指動脈擴張,比平常動脈壁更弱化的症狀。然後,大腦動脈產生的動脈瘤為腦動脈瘤和顱內動脈瘤。強化弱化的動脈,使血流順暢,不受膨脹的影響支撐流動。這樣的支架,用於腦相關發作的治療。全球顱內支架市場2013∼2018年的年複合成長率(CAGR)預計達到18.75%。

本報告提供全球的顱內支架市場相關分析、市場概要和結構、市場規模趨勢(今後5年的預測值)、各產品、各地區的詳細趨勢、開發中產品臨床實驗的進展、推動、阻礙市場要素與其影響力、主要企業簡介、今後的市場機會等調查、考察。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 法規環境
  • 波特的五力分析

第7章 支架的市場區隔:各類型

第8章 地理區隔

第9章 購買標準

第10章 臨床實驗後期階段的開發中產品

  • 後期開發中產品的主要資訊
    • Cordis:神經血管性自擴張性支架系統
    • Penumbra:Liberty支架系統
    • MicroVention:改變血流用管腔內設備(FRED)系統
    • 低架視覺化管腔內支援(Low Profile Visualized Intraluminal Support)

第11章 市場成長因素

第12章 成長因素與其影響

第13章 市場課題

第14章 成長因素與課題的影響

第15章 市場趨勢

第16章 趨勢與其影響

第17章 業者情勢

  • 競爭模式
  • 主要消息
  • 企業合併、收購(M&A)
  • 市場佔有率分析
  • 其他卓越供應商

第18章 主要供應商分析

  • Covidien PLC
    • 主要資料
    • 產業概要
    • 產業區分
    • 各部門的銷售額
    • 各地區的銷售額
    • 產業策略
    • 主要資訊
    • SWOT分析
  • DePuy Synthes
  • Medtronic
  • Micro Port Scientific
  • OBEX Medical
  • Stryker

第19章 相關報告

圖表一覽

目錄
Product Code: IRTNTR4313

About Intracranial Stents

Intracranial stents are stainless steel mesh-like tubes with anatomic features to achieve a perfect combination of radial strength and flexibility. Intracranial stents are used in the treatments of cerebral aneurysms, intracranial aneurysms, and intracranial atherosclerosis that cause about eight percent of all ischemic strokes. Aneurysm is a condition in which the artery widens and becomes weaker than a normal artery wall. Aneurysm is the result of high blood pressure and other factors such as aging, smoking, intracranial hypertension, and cerebrovascular complications. A type of aneurysm involving cerebral artery is called cerebral aneurysm or intracranial aneurysm. Intracranial stents help in strengthening the weakened artery, allowing smooth blood flow, without causing any effect to the bulge. These stents are used to treat cerebral-related strokes.

TechNavio's analysts forecast the Global Intracranial Stents market to grow at a CAGR of 18.75 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Intracranial Stents market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of intracranial stents.

TechNavio's report, Global Intracranial Stents Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC, and the EMEA regions; it also presents the vendor landscape and a corresponding detailed analysis of the top six vendors in the Global Intracranial Stents market. In addition, it discusses the major drivers that influence the growth of the market, the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Covidien
  • DePuy Synthes
  • Medtonic
  • MicroPort Scientific
  • OBEX Medical
  • Stryker

Other Prominent Vendors

  • Abbott Laboratories
  • Admedes Schuessler
  • BALT Extrusion
  • Cardiatis
  • Penumbra

Market Driver

  • Increased Incidence of Cerebral Disorders

For a full, detailed list, view our report

Market Challenge

  • Risk of Complication in Cerebrovascular/Neurovascular Procedures

For a full, detailed list, view our report

Market Trend

  • Rise in Demand for Intracranial Stenting Procedures

For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
    • Regulatory Environment
  • 06.3. Five Forces Analysis

07. Market Segmentation by Type of Stents

08. Geographical Segmentation

09. Buying Criteria

10. Late-stage Pipeline Products

  • 10.1. Key Information for Late-stage Pipeline Products
    • 10.1.1. Cordis Neurovascular Self Expanding Stent System
    • 10.1.2. Penumbra Liberty Stent System
    • 10.1.3. MicroVention Flow Redirection Intraluminal Device (FRED) system
    • 10.1.4. Low Profile Visualized Intraluminal Support

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Mergers and Acquisitions
  • 17.2. Market Share Analysis 2013
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Covidien Plc
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Business Segmentation
    • 18.1.4. Business Segmentation by Revenue 2012 and 2013
    • 18.1.5. Sales by Geography
    • 18.1.6. Business Strategy
    • 18.1.7. Key Information
    • 18.1.8. SWOT Analysis
  • 18.2. DePuy Synthes
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Business Units
    • 18.2.4. Business Strategy
    • 18.2.5. Recent Developments
    • 18.2.6. SWOT Analysis
  • 18.3. Medtronic
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation by Revenue 2013
    • 18.3.4. Business Segmentation by Revenue 2012 and 2013
    • 18.3.5. Geographical Segmentation by Revenue 2013
    • 18.3.6. Business Strategy
    • 18.3.7. Recent Developments
    • 18.3.8. SWOT Analysis
  • 18.4. MicroPort Scientific
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. Business Segmentation by Revenue 2013
    • 18.4.4. Business Segmentation by Revenue 2012 and 2013
    • 18.4.5. Geographical Segmentation by Revenue 2013
    • 18.4.6. Business Strategy
    • 18.4.7. Recent Developments
    • 18.4.8. SWOT Analysis
  • 18.5. OBEX Medical
    • 18.5.1. Key Facts
    • 18.5.2. Business Overview
    • 18.5.3. Product Segmentation
    • 18.5.4. SWOT Analysis
  • 18.6. Stryker
    • 18.6.1. Key Facts
    • 18.6.2. Business Overview
    • 18.6.3. Business Segmentation by Revenue 2013
    • 18.6.4. Business Segmentation by Revenue 2012 and 2013
    • 18.6.5. Geographical Segmentation by Revenue 2013
    • 18.6.6. Business Strategy
    • 18.6.7. Recent Developments
    • 18.6.8. SWOT Analysis

19. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Intracranial Stents Market 2013-2018 (US$ million)
  • Exhibit 3: FDA Classification on Medical Device by types of Classes
  • Exhibit 4: Global Intracranial Stents Market Segmentation by Type of Stents
  • Exhibit 5: Global Intracranial Stent Market by Geographical Segmentation 2013
  • Exhibit 6: Pipeline Snapshot of Intracranial Stents
  • Exhibit 7: Covidien plc: Business Segmentation 2013
  • Exhibit 8: Covidien plc: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 9: Covidien plc: Sales by Geography 2013
  • Exhibit 10: DePuy Synthes: Business Units
  • Exhibit 11: Medtronic: Business Segmentation by Revenue 2013
  • Exhibit 12: Medtronic: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 13: Medtronic: Geographical Segmentation by Revenue 2013
  • Exhibit 14: MicroPort Scientific: Business Segmentation by Revenue 2013
  • Exhibit 15: MicroPort Scientific: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 16: MicroPort Scientific: Geographical Segmentation by Revenue 2013
  • Exhibit 17: OBEX Medical: Product Segmentation
  • Exhibit 18: Stryker: Business Segmentation by Revenue 2013
  • Exhibit 19: Stryker: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 20: Stryker: Geographical Segmentation by Revenue 2013
Back to Top